Adding clinical variables (such as age and gender) into the model, it is worth noting that the GALAD score, which is the combination of clinical factors (gender, age) and biomarkers (AFP, AFP-L3, and Des-carboxyprothrombin), has been validated to improve the performance of discerning between HCC and cirrhosis [55]. This evidence concerns the gene AFP and Cirrhosis.